Charles Schwab’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,567	Closed	-$50.5K	–	3605
2022 Q4	$50.5K	Hold	1,567	–	–	﹤0.01%	3357
2022 Q3	$66K	Sell	1,567 -4,396	-74%	-$201K	﹤0.01%	3272
2022 Q2	$252K	Sell	5,963 -4,287	-42%	-$199K	﹤0.01%	3214
2022 Q1	$695K	Buy	10,250 +167	+2%	+$13.9K	﹤0.01%	2991
2021 Q4	$1.23M	Buy	10,083 +349	+4%	+$58.9K	﹤0.01%	2837
2021 Q3	$1.37M	Buy	9,734 +125	+1%	+$24.8K	﹤0.01%	2779
2021 Q2	$2.64M	Buy	9,609 +1,089	+13%	+$275K	﹤0.01%	2620
2021 Q1	$1.82M	Buy	8,520 +1,892	+29%	+$523K	﹤0.01%	2690
2020 Q4	$1.6M	Sell	6,628 -586	-8%	-$72.5K	﹤0.01%	2654
2020 Q3	$761K	Buy	7,214 +3,544	+97%	+$323K	﹤0.01%	2746
2020 Q2	$360K	Buy	3,670 +258	+8%	+$22.6K	﹤0.01%	2964
2020 Q1	$257K	Buy	3,412 +51	+2%	+$4.86K	﹤0.01%	2938
2019 Q4	$273K	Sell	3,361 -442	-12%	-$49.5K	﹤0.01%	2995
2019 Q3	$465K	Buy	3,803 +1,598	+72%	+$220K	﹤0.01%	2829
2019 Q2	$397K	Buy	2,205 +154	+8%	+$24.9K	﹤0.01%	2917
2019 Q1	$329K	Buy	2,051 +24	+1%	+$4.75K	﹤0.01%	2915
2018 Q4	$528K	Buy	2,027 +829	+69%	+$167K	﹤0.01%	2745
2018 Q3	$292K	Buy	1,198 +69	+6%	+$18.1K	﹤0.01%	3011
2018 Q2	$267K	Buy	+1,129	New	+$329K	﹤0.01%	3011

Other funds holding EVLO